Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.
Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.
复制标题
DOI:
10.1007/s11095-020-02889-7
复制
发表时间:
2020-08-30
影响因子:
3.7
通讯作者:
Longest PW
中科院分区:
文献类型:
--
作者:
Farkas D;Bonasera S;Bass K;Hindle M;Longest PW
Available dry powder inhalers (DPIs) have very poor lung delivery efficiencies in children. The objective of this study was to advance and experimentally test a positive-pressure air-jet DPI for children based on the use of a vertical aerosolization chamber and new patient interfaces that contain a three-dimensional (3D) rod array structure. Aerosolization performance of different air-jet DPI designs was first evaluated based on a 10 mg powder fill mass of a spray-dried excipient enhanced growth (EEG) formulation. Devices were actuated with positive pressure using flow rate (10-20 L/min) and inhaled volume (750 ml) conditions consistent with a 5-year-old child. Devices with best performance were connected to different mouthpiece designs to determine the effect on aerosolization and tested for aerosol penetration through a realistic pediatric in vitro mouth-throat model. Use of the new vertical aerosolization chamber resulted in high quality aerosol formation. Inclusion of a 3D rod array structure in the mouthpiece further reduced aerosol size by approximately 20% compared to conditions without a rod array, and effectively dissipated the turbulent jet leaving the device. Best case device and mouthpiece combinations produced <2% mouth-throat depositional loss and >70% lung delivery efficiency based on loaded dose. In conclusion, use of a 3D rod array in the MP of a positive-pressure air-jet DPI was found to reduce aerosol size by 20%, not significantly increase MP depositional loss, reduce mouth-throat deposition by 6.4-fold and enable lung delivery efficiency as high as 73.4% of loaded dose based on pediatric test conditions.
登录
查看更多内容
影响因子:
5.4
作者:
Lindert S;Below A;Breitkreutz J
通讯作者:
Breitkreutz J
DOI:
10.1089/jamp.2019.1540
发表时间:
2019-08-29
影响因子:
3.4
作者:
Farkas, Dale;Hindle, Michael;Longest, Worth
通讯作者:
Longest, Worth
影响因子:
5.8
作者:
Behara, Srinivas R. B.;Longest, P. Worth;Farkas, Dale R.;Hindle, Michael
通讯作者:
Hindle, Michael
DOI:
10.1136/adc.67.7_spec_no.826
发表时间:
1992-07-01
影响因子:
4.4
作者:
EVERARD, ML;STAMMERS, J;MILNER, AD
通讯作者:
MILNER, AD
影响因子:
4.5
作者:
Bass K;Longest PW
通讯作者:
Longest PW